Abstract |
We present the case of a 60-year-old female patient with systemic sclerosis complicated by pulmonary hypertension. Ten days after the initiation of treatment with bosentan, high fever and skin eruptions were noted. In the previous reports, the frequency of drug-induced skin eruptions has not been well documented. Since the use of bosentan is expected to increase, we should be aware of the previously unknown adverse effects as well as skin eruptions.
|
Authors | Yayoi Nagai, Masayoshi Yamanaka, Shigeru Nishimura, Akihiko Nakano, Akira Hasegawa, Osamu Ishikawa |
Journal | Modern rheumatology
(Mod Rheumatol)
Vol. 16
Issue 3
Pg. 188-90
( 2006)
ISSN: 1439-7595 [Print] England |
PMID | 16767560
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Antihypertensive Agents
- Endothelin Receptor Antagonists
- Sulfonamides
- Prednisolone
- Bosentan
|
Topics |
- Anti-Inflammatory Agents
(administration & dosage)
- Antihypertensive Agents
(adverse effects)
- Bosentan
- Drug Eruptions
- Endothelin Receptor Antagonists
- Eosinophilia
(etiology)
- Female
- Humans
- Hypertension, Pulmonary
(complications, drug therapy)
- Middle Aged
- Prednisolone
(administration & dosage)
- Scleroderma, Systemic
(complications)
- Sulfonamides
(adverse effects)
|